We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer

This study is currently recruiting participants.
Verified May 2017 by Bryan Schneider, MD, Hoosier Cancer Research Network
Sponsor:
ClinicalTrials.gov Identifier:
NCT02101385
First Posted: April 2, 2014
Last Update Posted: May 3, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborators:
Hoosier Cancer Research Network
Vera Bradley Foundation for Breast Cancer
Walther Cancer Institute
Strategic Research Initiative Grant through IUSCC
Information provided by (Responsible Party):
Bryan Schneider, MD, Hoosier Cancer Research Network
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2021
  Estimated Primary Completion Date: June 2021 (Final data collection date for primary outcome measure)